If you have any question, please feel free to email us. We will touch with you as soon as possible.
Fabrazyme is indicated for long-term enzyme replacement therapy in patients diagnosed with Fabry disease (alpha-galactosidase A deficiency). For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
Generic name | Agalsidase Beta for Injection |
Trade name | Fabrazyme |
Specification |
5mg/vial 35mg/vial |
Main ingredients | Agalsidase Beta |
Appearance | White or white - like freeze-dried lump or powder. |
MA Holder | Genzyme Europe B.V. |
Manufacturer | Genzyme Ireland Limited |
Indications |
Fabrazyme is indicated for long-term enzyme replacement therapy in patients diagnosed with Fabry disease (alpha-galactosidase A deficiency).
|
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: Fabrazyme 5mg 35mg Agalsidase Beta For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Acarbose Tablets, Olanzapine Tablets, Phenytoin Sodium Tablets, Reference Listed Drugs, AdapaleneGel, Alfacalcidol Soft Capsules
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China